Nu Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,836 | 160,204 | 145,713 | 128,634 | 107,515 |
| Depreciation Amortization | 12,342 | 52,261 | 39,349 | 27,258 | 14,206 |
| Income taxes - deferred | 1,723 | 20 | -8,154 | -6,793 | 631 |
| Accounts receivable | -5,737 | 10,055 | 1,318 | -8,660 | -5,878 |
| Accounts payable and accrued liabilities | 2,750 | -9,112 | -6,865 | -6,824 | -1,439 |
| Other Working Capital | -35,471 | -69,619 | -41,183 | -26,294 | -18,812 |
| Other Operating Activity | 18,638 | -63,523 | -66,513 | -71,137 | -95,834 |
| Operating Cash Flow | $-3,919 | $80,286 | $63,665 | $36,184 | $389 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,714 | -34,277 | -23,517 | -13,602 | -13,584 |
| Net Acquisitions | N/A | 193,725 | 193,725 | 193,725 | 193,725 |
| Purchase Of Investment | -573 | N/A | 0 | 0 | N/A |
| Sale Of Investment | N/A | 10,214 | 10,214 | 10,214 | 1,403 |
| Other Investing Activity | 0 | 1,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-14,287 | $170,662 | $180,422 | $190,337 | $181,544 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 225,000 | 55,000 | 55,000 | 15,000 | N/A |
| Debt Repayment | -225,489 | -227,238 | -221,755 | -161,120 | -155,621 |
| Common Stock Issued | -4,157 | -1,912 | -1,171 | -1,142 | -1,162 |
| Common Stock Repurchased | -5,011 | -20,040 | -10,020 | -5,012 | -5,012 |
| Dividend Paid | -2,873 | -11,834 | -8,928 | -5,966 | -3,002 |
| Other Financing Activity | -7,869 | 3,620 | 2,971 | 1,213 | -1,498 |
| Financing Cash Flow | $-20,399 | $-202,404 | $-183,903 | $-157,027 | $-166,295 |
| Exchange Rate Effect | -1,371 | 3,203 | 4,720 | 7,782 | 1,249 |
| Beginning Cash Position | 238,630 | 186,883 | 186,883 | 186,883 | 186,883 |
| End Cash Position | 198,654 | 238,630 | 251,787 | 264,159 | 203,770 |
| Net Cash Flow | $-39,976 | $51,747 | $64,904 | $77,276 | $16,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,919 | 80,286 | 63,665 | 36,184 | 389 |
| Capital Expenditure | -13,714 | -34,277 | -23,517 | -13,602 | -13,584 |
| Free Cash Flow | -17,633 | 46,009 | 40,148 | 22,582 | -13,195 |